Statement of Deviation & Variation for the half year ended March 31, 2025. Detailed annexure attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aelea Commodities has filed a routine compliance statement for the half year ended March 31, 2025, confirming that IPO proceeds raised on July 18, 2024 (totaling about ₹51 crore) have been used strictly as per the original plans stated in the prospectus. The company has reported NO deviation or variation in the use of funds. The full ₹51 crore was originally earmarked across four heads: ₹25.53 crore for setting up a new manufacturing unit with plant & machinery, ₹5.92 crore for purchasing plant & machinery at the existing unit, ₹12.74 crore for general corporate purposes, and ₹6.81 crore for issue-related expenses. The revised/modified allocation and the deviation amount are both shown as zero, meaning every rupee is on track.
This is a neutral-to-slightly-positive compliance filing — it confirms the company is using shareholders' IPO money responsibly and exactly as promised, with no scope creep or misuse. No immediate impact on stock price is expected, as no red flags were raised.